ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2487 participants.

Also called NCT03507777

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,487 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03507777
Other papers using this trial's data
  • Impact of Optical Coherence Tomography-Based Post-PCI Physiology Assessment to Predict Clinical Outcomes: An ILUMIEN-IV Substudy Journal of the American College of Cardiology, 2025-07-15 DOI, PubMed 40406943
  • OCT-Defined Plaque Morphology and Clinical Outcomes After Percutaneous Coronary Intervention: An ILUMIEN IV Substudy JACC. Cardiovascular imaging, 2026-08 DOI, PubMed 42547197
  • OCT-Guided vs Angiography-Guided Coronary Stent Implantation in Complex Lesions: An ILUMIEN IV Substudy Journal of the American College of Cardiology, 2024-07-23 DOI, PubMed 38759907
  • Optical Coherence Tomography-Guided versus Angiography-Guided PCI The New England journal of medicine, 2023-10-19 DOI, PubMed 37634188
  • Safety and Efficacy of Cobalt Chromium Everolimus-Eluting Stents for Treatment of In-Stent Restenosis: An ILUMIEN IV Substudy Journal of the American Heart Association, 2025-06-03 DOI, PubMed 40401609, PMC12229119 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Belgium, Canada, Denmark, France, Germany, Hong Kong SAR China, India, Italy, Japan, Netherlands, New Zealand, Portugal, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03507777. Randomized; double masking; primary purpose treatment. Start 2018-05-17 (actual); primary completion 2023-02-28 (actual). Results posted on 2024-08-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)
Condition
Coronary Stenosis
Condition
Atherosclerosis
Condition
STEMI
Condition
STEMI - ST Elevation Myocardial Infarction
Condition
NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
Intervention (Device)
Coronary PCI (percutaneous coronary intervention) guided by OCT
Intervention (Device)
Coronary PCI guided by Angiography
Lead sponsor
Abbott Medical Devices (class: industry)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct03507777
Content hash
7540b24d6030dcbaf078e8ee240ae591eb8592b185c36eda96128ec1dc66ddaf